![IJMS | Free Full-Text | Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm? IJMS | Free Full-Text | Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?](https://www.mdpi.com/ijms/ijms-24-12634/article_deploy/html/images/ijms-24-12634-g002-550.jpg)
IJMS | Free Full-Text | Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?
![PDF) First use of cenerimod, a selective S1P 1 receptor modulator, for the treatment of SLE: A double-blind, randomised, placebo-controlled, proof-of-concept study PDF) First use of cenerimod, a selective S1P 1 receptor modulator, for the treatment of SLE: A double-blind, randomised, placebo-controlled, proof-of-concept study](https://i1.rgstatic.net/publication/337152901_First_use_of_cenerimod_a_selective_S1P_1_receptor_modulator_for_the_treatment_of_SLE_A_double-blind_randomised_placebo-controlled_proof-of-concept_study/links/5dc8048f4585151435fd595a/largepreview.png)
PDF) First use of cenerimod, a selective S1P 1 receptor modulator, for the treatment of SLE: A double-blind, randomised, placebo-controlled, proof-of-concept study
![IJMS | Free Full-Text | Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies IJMS | Free Full-Text | Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies](https://www.mdpi.com/ijms/ijms-23-15998/article_deploy/html/images/ijms-23-15998-g001-550.jpg)
IJMS | Free Full-Text | Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies
![Potent anti‐inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL‐S1P and their impairment in coronary artery disease due to lower HDL‐S1P: a new aspect of HDL dysfunction and its Potent anti‐inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL‐S1P and their impairment in coronary artery disease due to lower HDL‐S1P: a new aspect of HDL dysfunction and its](https://faseb.onlinelibrary.wiley.com/cms/asset/c01707ea-fb91-420b-8019-0fda83abf87f/fsb2fj201801245r-fig-0006-m.jpg)
Potent anti‐inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL‐S1P and their impairment in coronary artery disease due to lower HDL‐S1P: a new aspect of HDL dysfunction and its
![Sphingosine‐1‐phosphate receptor modulators in stroke treatment - Zhang - 2022 - Journal of Neurochemistry - Wiley Online Library Sphingosine‐1‐phosphate receptor modulators in stroke treatment - Zhang - 2022 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c60b2d48-a3f7-44ae-bb84-616954cb668b/jnc15685-fig-0001-m.jpg)
Sphingosine‐1‐phosphate receptor modulators in stroke treatment - Zhang - 2022 - Journal of Neurochemistry - Wiley Online Library
![Functions and interaction of plant lipid signalling under abiotic stresses - Liang - 2023 - Plant Biology - Wiley Online Library Functions and interaction of plant lipid signalling under abiotic stresses - Liang - 2023 - Plant Biology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2afedaaf-bf82-4538-a771-33566f36f9bd/plb13507-fig-0004-m.jpg)
Functions and interaction of plant lipid signalling under abiotic stresses - Liang - 2023 - Plant Biology - Wiley Online Library
![Targeting the Sphingosine Kinase/Sphingosine 1‐Phosphate Pathway to Treat Chronic Inflammatory Kidney Diseases - Schwalm - 2014 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library Targeting the Sphingosine Kinase/Sphingosine 1‐Phosphate Pathway to Treat Chronic Inflammatory Kidney Diseases - Schwalm - 2014 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aaf5edb9-a0a7-4b6e-b02d-9949b69a366e/bcpt12103-fig-0002-m.jpg)
Targeting the Sphingosine Kinase/Sphingosine 1‐Phosphate Pathway to Treat Chronic Inflammatory Kidney Diseases - Schwalm - 2014 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
![Biomedicines | Free Full-Text | Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article Biomedicines | Free Full-Text | Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article](https://www.mdpi.com/biomedicines/biomedicines-08-00227/article_deploy/html/images/biomedicines-08-00227-g001-550.jpg)
Biomedicines | Free Full-Text | Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article
![Potent anti‐inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL‐S1P and their impairment in coronary artery disease due to lower HDL‐S1P: a new aspect of HDL dysfunction and its Potent anti‐inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL‐S1P and their impairment in coronary artery disease due to lower HDL‐S1P: a new aspect of HDL dysfunction and its](https://faseb.onlinelibrary.wiley.com/cms/asset/54e68531-3c92-4427-bb54-2b36065e024d/fsb2fj201801245r-fig-0009-m.jpg)
Potent anti‐inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL‐S1P and their impairment in coronary artery disease due to lower HDL‐S1P: a new aspect of HDL dysfunction and its
![Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0008874920304032-gr4.jpg)
Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect
![Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives | Journal of Medicinal Chemistry Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b01575/asset/images/medium/jm-2016-01575f_0001.gif)
Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives | Journal of Medicinal Chemistry
![Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells - ScienceDirect Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S138819811300200X-gr1.jpg)
Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells - ScienceDirect
![Valproic acid enforces the priming effect of sphingosine-1 phosphate on human mesenchymal stem cells Valproic acid enforces the priming effect of sphingosine-1 phosphate on human mesenchymal stem cells](https://www.spandidos-publications.com/article_images/ijmm/40/3/IJMM-40-03-0739-g00.jpg)
Valproic acid enforces the priming effect of sphingosine-1 phosphate on human mesenchymal stem cells
![Biomedicines | Free Full-Text | Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article Biomedicines | Free Full-Text | Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article](https://pub.mdpi-res.com/biomedicines/biomedicines-08-00227/article_deploy/html/images/biomedicines-08-00227-g003.png?1595319779)
Biomedicines | Free Full-Text | Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article
![Cells | Free Full-Text | The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives Cells | Free Full-Text | The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives](https://pub.mdpi-res.com/cells/cells-09-01515/article_deploy/html/images/cells-09-01515-g001-550.jpg?1594110377)
Cells | Free Full-Text | The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives
![Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0008874920304032-gr5.jpg)
Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect
![Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives | Journal of Medicinal Chemistry Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b01575/asset/images/medium/jm-2016-01575f_0011.gif)
Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives | Journal of Medicinal Chemistry
![Sphingosine‐1‐phosphate receptor modulators in stroke treatment - Zhang - 2022 - Journal of Neurochemistry - Wiley Online Library Sphingosine‐1‐phosphate receptor modulators in stroke treatment - Zhang - 2022 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/31543b95-2fc2-428b-8197-506e306c2ab6/jnc15685-fig-0002-m.jpg)
Sphingosine‐1‐phosphate receptor modulators in stroke treatment - Zhang - 2022 - Journal of Neurochemistry - Wiley Online Library
![Bioactive Scaffolds as a Promising Alternative for Enhancing Critical-Size Bone Defect Regeneration in the Craniomaxillofacial Region | ACS Applied Bio Materials Bioactive Scaffolds as a Promising Alternative for Enhancing Critical-Size Bone Defect Regeneration in the Craniomaxillofacial Region | ACS Applied Bio Materials](https://pubs.acs.org/cms/10.1021/acsabm.3c00432/asset/images/large/mt3c00432_0006.jpeg)
Bioactive Scaffolds as a Promising Alternative for Enhancing Critical-Size Bone Defect Regeneration in the Craniomaxillofacial Region | ACS Applied Bio Materials
![Targeting the Sphingosine Kinase/Sphingosine 1‐Phosphate Pathway to Treat Chronic Inflammatory Kidney Diseases - Schwalm - 2014 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library Targeting the Sphingosine Kinase/Sphingosine 1‐Phosphate Pathway to Treat Chronic Inflammatory Kidney Diseases - Schwalm - 2014 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6604fba4-b5e3-4d89-a060-7dc030d30acb/bcpt12103-fig-0001-m.jpg)
Targeting the Sphingosine Kinase/Sphingosine 1‐Phosphate Pathway to Treat Chronic Inflammatory Kidney Diseases - Schwalm - 2014 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Whole Blood and Plasma-Based Lipid Profiling Reveals Distinctive Metabolic Changes in Systemic Lupus Erythematosus and Systemic Sclerosis | Journal of Proteome Research
![Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis ... Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00138/asset/images/medium/jm1c00138_0002.gif)
Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis ...
![Immune Responses at Host Barriers and Their Importance in Systemic Autoimmune Diseases | SpringerLink Immune Responses at Host Barriers and Their Importance in Systemic Autoimmune Diseases | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-3-031-26163-3_1/MediaObjects/541559_1_En_1_Fig1_HTML.png)
Immune Responses at Host Barriers and Their Importance in Systemic Autoimmune Diseases | SpringerLink
![IJMS | Free Full-Text | Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases IJMS | Free Full-Text | Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases](https://www.mdpi.com/ijms/ijms-24-01456/article_deploy/html/images/ijms-24-01456-g003.png)
IJMS | Free Full-Text | Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases
![Strategic outline of interventions targeting extracellular matrix for promoting healthy longevity | American Journal of Physiology-Cell Physiology Strategic outline of interventions targeting extracellular matrix for promoting healthy longevity | American Journal of Physiology-Cell Physiology](https://journals.physiology.org/cms/10.1152/ajpcell.00060.2023/asset/images/medium/c-00060-2023r01.png)
Strategic outline of interventions targeting extracellular matrix for promoting healthy longevity | American Journal of Physiology-Cell Physiology
![Cells | Free Full-Text | The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives Cells | Free Full-Text | The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives](https://www.mdpi.com/cells/cells-09-01515/article_deploy/html/images/cells-09-01515-g001.png)
Cells | Free Full-Text | The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives
![PDF) Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives PDF) Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives](https://i1.rgstatic.net/publication/361623897_Sphingosine-1-Phosphate_S1P_and_S1P_Signaling_Pathway_Modulators_from_Current_Insights_to_Future_Perspectives/links/62c889ce00d0b4511040dda7/largepreview.png)
PDF) Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
![FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice | Circulation FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice | Circulation](https://www.ahajournals.org/cms/asset/ffd9fde7-82d2-4bc8-8aa1-c95b4e68e31e/13ff6.jpg)
FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice | Circulation
![IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury](https://www.mdpi.com/ijms/ijms-23-04010/article_deploy/html/images/ijms-23-04010-g006-550.jpg)
IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury
![IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury](https://www.mdpi.com/ijms/ijms-23-04010/article_deploy/html/images/ijms-23-04010-g001-550.jpg)
IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury
![IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury](https://www.mdpi.com/ijms/ijms-23-04010/article_deploy/html/images/ijms-23-04010-g007-550.jpg)
IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury
![Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0008874920304032-gr3.jpg)
Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury - ScienceDirect
![Chemical structures of sphingosine 1-phosphate, fingolimod, siponimod... | Download Scientific Diagram Chemical structures of sphingosine 1-phosphate, fingolimod, siponimod... | Download Scientific Diagram](https://www.researchgate.net/profile/Bisera-Stepanovska-Tanturovska/publication/346845716/figure/fig3/AS:1066406061801472@1631262426059/Reported-mechanisms-of-action-of-cenerimod-on-several-cell-types-Based-on-references_Q320.jpg)
Chemical structures of sphingosine 1-phosphate, fingolimod, siponimod... | Download Scientific Diagram
![IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury IJMS | Free Full-Text | A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury](https://pub.mdpi-res.com/ijms/ijms-23-04010/article_deploy/html/images/ijms-23-04010-g008.png?1649408828)